ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

30 hedge funds and large institutions have $2.36M invested in Oramed Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
6
Reduced
5
Closed
2
Calls
$357K
Puts
$48K
Net Calls
+$309K
Net Calls Change
+$280K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$676K
2
TRCT
2
Tower Research Capital (TRC)
New York
$59K
3
Millennium Management
3
Millennium Management
New York
$50K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$47K
5
TI
5
Telemetry Investments
New York
$32K

Top Sellers

1
SM
1
Sabby Management
Florida
$593K
2
Jane Street
2
Jane Street
New York
$74K
3
PAM
3
Panagora Asset Management
Massachusetts
$0
4
BlackRock
4
BlackRock
New York
$228K
5
Simplex Trading
5
Simplex Trading
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SPIA
26
Steward Partners Investment Advisory
New York
$3K 1,000 – –
LTFS
27
Ladenburg Thalmann Financial Services
Florida
$2K 500 – –
JWA
28
JFS Wealth Advisors
Pennsylvania
$2K 500 – –
GT
29
Glenmede Trust
Pennsylvania
$63 20,000 – –
PAM
30
Panagora Asset Management
Massachusetts
– – -12,864 Closed
Simplex Trading
31
Simplex Trading
Illinois
– – -1,775 Closed
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
SFS
33
Sowell Financial Services
Arkansas
$0 128 +128 New
1
2